• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Imperial Innovations Group plc: Appointment of Paolo Paoletti as Executive Chairman of Kesios Therapeutics

    Imperial Innovations Group plc: Appointment of Paolo Paoletti as Executive Chairman of Kesios Therapeutics

  2. Research and Markets: 2015 Assessments of Leading Microbiology Market Players - Profiles of Major Suppliers and Recent Market Entrants

    Research and Markets: 2015 Assessments of Leading Microbiology Market Players - Profiles of Major Suppliers and Recent Market Entrants

  3. TBWA\Chiat\Day New York Awarded Creative Duties for Kenwood Vineyards

    TBWA\Chiat\Day New York Awarded Creative Duties for Kenwood Vineyards

  4. Research and Markets: Global Rectal Cancer Pipeline Report 2015 - 11 Companies & 12 Drug Profiles

    Research and Markets: Global Rectal Cancer Pipeline Report 2015 - 11 Companies & 12 Drug Profiles

  5. Research and Markets: Global Next Generation Sequencing Market 2015-2019 with Illumina, Roche Diagnostics & Thermo Fischer Scientific Dominating

    Research and Markets: Global Next Generation Sequencing Market 2015-2019 with Illumina, Roche Diagnostics & Thermo Fischer Scientific Dominating

  6. Research and Markets: Global Adult Vaccines Market & Company Analysis 2015-2020

    Research and Markets: Global Adult Vaccines Market & Company Analysis 2015-2020

  7. Pennsylvania Bio Announces Chairman-Elect and New Board Members

    Pennsylvania Bio Announces Chairman-Elect and New Board Members

  8. FDA Approves TREXIMET (sumatriptan and naproxen sodium) for Use in Pediatric Patients

    FDA Approves TREXIMET (sumatriptan and naproxen sodium) for Use in Pediatric Patients

  9. Research and Markets: Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025

    Research and Markets: Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025

  10. Vernalis and Tris Pharma receive FDA approval of NDA for Tuzistra™ XR (codeine polistirex and chlorpheniramine polistirex)

    Vernalis and Tris Pharma receive FDA approval of NDA for Tuzistra™ XR (codeine polistirex and chlorpheniramine polistirex)

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.